Kurtalic serves as a policy advisor for the British Pharmaceutical Industry (BPI)
Mona Kurtalic Takes on New Role as Advisor for Politics within the Federal Association of the Pharmaceutical Industry (BPI)
Mona Kurtalic, a seasoned health economist, has transitioned from her previous role as a scientific advisor for health policy in the FDP parliamentary group to her new position as Advisor for Politics within the Federal Association of the Pharmaceutical Industry (BPI) in Germany.
In her new role, Kurtalic will oversee the association's activities related to public relations, communication, and international affairs within the pharmaceutical sector. She will be working alongside Sebastian Schütze and Larissa Schmidt, colleagues who share a common goal of advocating for the pharmaceutical industry's interests in health policy.
Kurtalic's background as a health economist and her experience as a scientific advisor for health policy in the FDP parliamentary group have equipped her with the necessary skills for her new role at the BPI. Her expertise in health policy and economics is expected to contribute to the BPI's efforts to shape the future of the pharmaceutical industry in Germany.
The BPI, a significant organization in the pharmaceutical industry, represents the interests of various pharmaceutical companies in Germany. The focus on advocating for the pharmaceutical industry's interests in health policy aligns with Kurtalic's professional background and expertise.
Kurtalic's appointment to the BPI is seen as a strategic move to strengthen the organization's advocacy efforts in health policy. Her commitment to shaping health policy remains unchanged, as she transitions from the FDP parliamentary group to the BPI.
Kurtalic assumed her new role on January 1, 2022, and her primary responsibilities include shaping health policy and advocating for the pharmaceutical industry. Her previous role in the FDP parliamentary group has provided her with a unique perspective that will undoubtedly prove valuable in her new position.
The BPI is excited to welcome Kurtalic to their team and looks forward to the positive impact she will have on the organization and the pharmaceutical industry as a whole.
In her new position at the Federal Association of the Pharmaceutical Industry (BPI), Mona Kurtalic will utilize her knowledge in health policy and economics to contribute to the organization's health-and-wellness related activities, particularly in terms of shaping general-news and politics for the pharmaceutical sector. Kurtalic's expertise and experience, gained from her previous role in the FDP parliamentary group, will aid her in advocating for the industry's interests in health-and-wellness and policy-making circles.
){kind=link}